欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号IE/H/0754/001
药品名称Telmisartan and Hydrochlorothiazide 40/12.5 mg
活性成分
    • Hydrochlorothiazide 12.5 mg
    • Telmisartan 40.0 mg
剂型Tablet
上市许可持有人Accord Hcalthcare Limited. Sage house, 319 Pinner road, North Harrow. Middlesex, HA 1 4HF, UK
参考成员国 - 产品名称Ireland (IE)
互认成员国 - 产品名称
    • Lithuania (LT)
      Telmisartan/Hydrochlorothiazide Accord 40 mg/12,5 mg tabletės
    • Estonia (EE)
      TELMISARTAN/HYDROCHLOROTHIAZIDE ACCORD
    • Latvia (LV)
      Telmisartan/Hydrochlorothiazide Accord 40 mg/12,5 mg tabletes
    • United Kingdom (Northern Ireland) (XI)
      Telmisartan and Hydrochlorothiazide 40/12.5 mg
    • Germany (DE)
      Telmisartan/Hydrochlorthiazid Accord 40 mg/12,5 mg Tabletten
    • Netherlands (NL)
      Telmisartan/Hydrochloorthiazide Accord 40 mg/12,5 mg tabletten
    • Austria (AT)
      Telmisartan/Hydrochlorothiazid Accord 40 mg/12,5 mg Tabletten
    • France (FR)
    • Italy (IT)
    • Finland (FI)
许可日期2016/02/10
最近更新日期2024/12/11
药物ATC编码
    • C09DA07 telmisartan and diuretics
申请类型
  • TypeLevel1:[not specified]
  • TypeLevel2:[not specified]
  • TypeLevel3:[not specified]
  • TypeLevel4:[not specified]
  • TypeLevel5:[not specified]
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase